Arkansas Doc Loses Prescription Power in DEA Smackdown
Published Date: 1/27/2026
Notice
Summary
Dr. Adam Maass from Arkansas lost his DEA registration because he can’t legally handle controlled substances in his state anymore. He didn’t ask for a hearing, so the DEA canceled his registration by default. This means he must stop prescribing or handling controlled drugs immediately, affecting his medical practice and any related income.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
DEA Registration Revoked; Renewals Denied
The DEA revoked Adam Maass, M.D.'s Certificate of Registration No. BM6528369 and denied any pending applications to renew, modify, or add registration in Arkansas. The Order follows his March 5, 2025 guilty plea, his April 25, 2025 surrender of his Arkansas medical license (currently listed as "Inactive"), and his failure to request a hearing; the Order is effective "[insert Date Thirty Days From the Date of Publication in the Federal Register]."
15-Day Right To Seek Reconsideration
The Agency took official notice that Dr. Maass's Arkansas medical license is "Inactive," and the Order states he may file a properly supported motion for reconsideration of the findings of fact within fifteen calendar days of the date of the Order. Any such motion and response must be filed and served by email, including to the DEA Office of the Administrator at [email protected].
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20749, Vladimir Romaniv, P.A.; Decision and Order
The DEA has officially suspended and is moving to revoke Vladimir Romaniv, P.A.'s registration because he gave multiple prescriptions without properly checking on a patient who was in jail. This affects Romaniv’s ability to prescribe controlled substances and signals serious legal trouble starting from late 2025. If you’re connected to his practice or rely on his prescriptions, expect changes and tighter controls soon.
2026-20750, L Krenk DBA Maui Clinic Pharmacy; Decision and Order
The DEA has officially revoked L Krenk DBA Maui Clinic Pharmacy’s registration because they broke important rules about where and how they handled controlled substances. This affects the pharmacy in Kahului, Hawaii, which can no longer legally dispense these drugs. The decision is final, and the pharmacy missed its chance to defend itself, so the revocation takes effect immediately, impacting their business and customers.
Previous / Next Documents
Previous: 2026-01498, Complete Care Pharmacy, LLC; Decision and Order
Complete Care Pharmacy in New Mexico lost its DEA license because its owner filled 26 drug prescriptions without having the legal authority to do so. This means the pharmacy can no longer handle controlled substances, impacting its business immediately. Anyone relying on this pharmacy for such medications will need to find a new provider fast.
Next: 2026-01500, Arms Sales Notification
The U.S. Department of Defense is updating Congress about a big arms sale to Australia, including 29 Apache attack helicopters and lots of high-tech gear and missiles. This deal, first notified in 2021, involves advanced upgrades to make the equipment even better. It’s a major move that keeps Australia’s defense strong and shows ongoing U.S. support with cutting-edge military tech.